Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Almirall, S.A.

Medicines register · Ireland

Almirall, S.A. — licensed medicines

23 medicines held by Almirall, S.A. on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 07 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Almogran 12.5 mg film-coated tablet PA0968/001/001

Almotriptan

Marketed

Ebglyss 250 mg solution for injection in pre-filled pen EU/1/23/1765/007-012

Lebrikizumab

—

Ebglyss 250 mg solution for injection in pre-filled syringe EU/1/23/1765/001-006

Lebrikizumab

—

Ilumetri 100 mg solution for injection in pre-filled syringe EU/1/18/1323/001-002

Tildrakizumab

—

Ilumetri 200 mg solution for injection in pre-filled syringe EU/1/18/1323/003

Tildrakizumab

—

Klisyri 10 mg/g ointment EU/1/21/1558/001

Tirbanibulin

—

Meptid 100 mg/ml Solution for Injection PA0968/005/001

Meptazinol

Not marketed

Meptid 200 mg film-coated Tablets PA0968/005/002

Meptazinol

Marketed

Prometax 1.5 mg hard capsules EU/1/98/092/001-003

Rivastigmine hydrogen tartrate

—

Prometax 13.3 mg/24 h transdermal patch EU/1/98/092/027-030

Rivastigmine

—

Prometax 2 mg/ml oral solution EU/1/98/092/013

Rivastigmine hydrogen tartrate

—

Prometax 3.0 mg hard capsules EU/1/98/092/004-006

Rivastigmine hydrogen tartrate

—

Prometax 4.5 mg hard capsules EU/1/98/092/007-009

Rivastigmine hydrogen tartrate

—

Prometax 4.6 mg/24 h transdermal patch EU/1/98/092/19-22

Rivastigmine

—

Prometax 6.0 mg hard capsules EU/1/98/092/010-012

Rivastigmine hydrogen tartrate

—

Prometax 9.5 mg/24 h transdermal patch EU/1/98/092/23-26

Rivastigmine

—

Skilarence 120 mg gastro-resistant tablets EU/1/17/1201/002-011

Dimethyl Fumarate

—

Skilarence 30 mg gastro-resistant tablets EU/1/17/1201/001

Dimethyl Fumarate

—

Solaraze 3% gel PA0968/004/001

Diclofenac sodium

Marketed

Vaniqa 11.5% EU/1/01/173/002

Eflornithine

—

Vaniqa 11.5% EU/1/01/173/003

Eflornithine

—

Vaniqa 11.5% cream EU/1/01/173/001

Eflornithine

—

Wynzora 50 micrograms/g + 0.5 mg/g cream PA0968/006/001

Calcipotriol, Betamethasone

Not marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 7 October 2026. https://priyalifescience.com/medicines/company/almirall-s-a

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.